GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmaresearch Bio Co Ltd (XKRX:217950) » Definitions » Enterprise Value

Pharmaresearch Bio Co (XKRX:217950) Enterprise Value : ₩97,210 Mil (As of May. 28, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Pharmaresearch Bio Co Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Pharmaresearch Bio Co's Enterprise Value is ₩97,210 Mil. Pharmaresearch Bio Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₩7,388 Mil. Therefore, Pharmaresearch Bio Co's EV-to-EBIT ratio for today is 13.16.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Pharmaresearch Bio Co's Enterprise Value is ₩97,210 Mil. Pharmaresearch Bio Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was ₩8,391 Mil. Therefore, Pharmaresearch Bio Co's EV-to-EBITDA ratio for today is 11.58.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Pharmaresearch Bio Co's Enterprise Value is ₩97,210 Mil. Pharmaresearch Bio Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₩20,031 Mil. Therefore, Pharmaresearch Bio Co's EV-to-Revenue ratio for today is 4.85.


Pharmaresearch Bio Co Enterprise Value Historical Data

The historical data trend for Pharmaresearch Bio Co's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaresearch Bio Co Enterprise Value Chart

Pharmaresearch Bio Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial 40,733.95 58,108.02 102,493.16 91,131.07 63,495.91

Pharmaresearch Bio Co Semi-Annual Data
Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value Get a 7-Day Free Trial 40,733.95 58,108.02 102,493.16 91,131.07 63,495.91

Competitive Comparison of Pharmaresearch Bio Co's Enterprise Value

For the Biotechnology subindustry, Pharmaresearch Bio Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmaresearch Bio Co's Enterprise Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmaresearch Bio Co's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Pharmaresearch Bio Co's Enterprise Value falls into.



Pharmaresearch Bio Co Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Pharmaresearch Bio Co's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

Pharmaresearch Bio Co's Enterprise Value for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharmaresearch Bio Co  (XKRX:217950) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Pharmaresearch Bio Co's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=97209.511/7388.331
=13.16

Pharmaresearch Bio Co's current Enterprise Value is ₩97,210 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Pharmaresearch Bio Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₩7,388 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Pharmaresearch Bio Co's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=97209.511/8391.091
=11.58

Pharmaresearch Bio Co's current Enterprise Value is ₩97,210 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Pharmaresearch Bio Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was ₩8,391 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Pharmaresearch Bio Co's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=97209.511/20030.641
=4.85

Pharmaresearch Bio Co's current Enterprise Value is ₩97,210 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Pharmaresearch Bio Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₩20,031 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharmaresearch Bio Co Enterprise Value Related Terms

Thank you for viewing the detailed overview of Pharmaresearch Bio Co's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmaresearch Bio Co (XKRX:217950) Business Description

Traded in Other Exchanges
N/A
Address
641-3, Saimdang-ro, Gangwon-do, Gangneung-si, KOR, 13494
Pharmaresearch Bio Co Ltd is a Korea-based biopharmaceutical company. The company is engaged in the research and development, manufacturing, sale, and marketing of biopharmaceutical products. Its product is ReNTox Injections, and Clostridium Botulinum Toxin type A is in pipeline.

Pharmaresearch Bio Co (XKRX:217950) Headlines

No Headlines